FPS
GRCL

Fieldpoint Private Securities’s Gracell Biotechnologies Inc. American Depositary Shares GRCL Stock Holding History

Fieldpoint Private Securities’s Portfolio GRCL Stock Details GRCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-160
Closed -$1K – 1760
2021
Q4 		$1K Buy
+160
New +$1K ﹤0.01% 1629